MR编号 | NL/H/3183/001 |
---|
药品名称 | LCE 50 mg/12,5 mg /200 mg, film-coated tablets |
---|
活性成分 | - carbidopa 12.5 mg
- entacapone 200.0 mg
- levodopa 50.0 mg
|
---|
剂型 | Film-coated tablet |
---|
上市许可持有人 | Generics [UK] Limited
Station Close, Potters Bar, Herfordshire
EN6 1TL
United Kingdom |
---|
参考成员国 - 产品名称 | Netherlands (NL) Levodopa/Carbidopa/Entacapone Mylan 50/12.5/200 mg, filmomhulde tabletten |
---|
互认成员国 - 产品名称 | - Czechia (CZ)
LEVODOPA/CARBIDOPA/ENTACPONE MYLAN 50/12.5/200 mg, potahované tablety - Greece (GR)
LEVODOPA+CARBIDOPA+ENTACAPONE/MYLAN - Spain (ES)
- France (FR)
- Ireland (IE)
- Italy (IT)
- Slovakia (SK)
Levodopa/Carbidopa/Entacapone Mylan 50/12,5/200 mg - United Kingdom (GB)
|
---|
许可日期 | 2014/10/01 |
---|
最近更新日期 | 2014/10/02 |
---|
药物ATC编码 | - N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
|
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|